For instance, indoor cats have little risk of exposure to many diseases compared to outside cats, so they can be safe receiving
fewer types of vaccinations less frequently than their outdoor peers.
According to Sullivan, this technology can be used to rapidly respond to many
types of diseases, as the development time from first
vaccination to high - titer, fully human polyclonal antibody is just a
few months.